Jan Torzewski

Head/Professor

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Tissue Engineering Tissue Engineering professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jan Torzewski is a Professor at the Clinic Association Allgaeu in Germany. His research primarily focuses on coronary physiology, clinical outcomes of resorbable scaffolds, and the role of inflammatory markers in cardiovascular diseases. Recent articles authored by Professor Torzewski explore advancements in intravascular imaging and clinical trial designs aimed at improving outcomes in coronary artery interventions.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Peter Nordbeck

GERMANY

View details

Andreas Schuster

GERMANY

View details

Bastian Wein

University Hospital Augsburg

GERMANY

View details

Erion Xhepa

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jan Torzewski

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Changes in Coronary Physiology by μFR Measurement After DREAMS-3G-Scaffold Implantation

Editorial: Targeting the interleukin-1β/interleukin-6/C-reactive protein pathway in clinical medicine - a road map to clinical trial design

Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study.

Selective C-reactive protein apheresis in acute myocardial infarction: rationale and design of a prospective international randomized controlled trial

The Impact of Underlying Plaque Characteristics Following the Third‐Generation Resorbable Magnesium Scaffold Implantation: An Intravascular OCT Assessment up to 12‐Months

Vascular response following implantation of the third-generation drug-eluting resorbable coronary magnesium scaffold: an intravascular imaging analysis of the BIOMAG-I first-in-human study

Case Report: C-reactive protein apheresis in non-ST-elevation ACS—case series from the C-reactive protein apheresis in Acute Myocardial Infarction Registry

A short review on CRP synthesis inhibition in cardiovascular disease

Imaging Predictors of Left Ventricular Functional Recovery after Reperfusion Therapy of ST-Elevation Myocardial Infarction Assessed by Cardiac Magnetic Resonance

One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry.

A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-1 first-in-human study.

Five-Year Clinical Outcomes After Coronary Bioresorbable Scaffolds and Drug-Eluting Stents: The ABSORB IV Randomized Trial

Safety and performance of the third-generation drug-eluting resorbable coronary magnesium scaffold system in the treatment of subjects with de novo coronary artery lesions: 6-month results of the prospective, multicenter BIOMAG-I first-in-human study

Case report: C-reactive protein apheresis in cardiogenic shock: case series from the C-reactive protein apheresis in acute myocardial infarction-registry

Temporal Changes in Coronary Plaque as Assessed by an Artificial Intelligence Based Optical Coherence Tomography: From the First-in-Human Trial on DREAMS 3G Scaffold.

Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study

Cardiac Glycosides Lower C-Reactive Protein Plasma Levels in Patients with Decompensated Heart Failure: Results from the Single-Center C-Reactive Protein-Digoxin Observational Study (C-DOS)

Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons

A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry.

No Difference in 30-Day Outcome and Quality of Life in Transradial Versus Transfemoral Access - Results From the German Austrian ABSORB Registry (GABI-R).

Collaborators (4)

Peter Nordbeck

Andreas Schuster

Bastian Wein

Erion Xhepa

Make your next move.